| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $776K | +36.4% |
| SG&A Expense | $733K | +4.3% |
| Operating Income | -$1.5M | -18.6% |
| Net Income | -$1.5M | -18.3% |
| EPS (Basic) | $0.08 | +14.3% |
| EPS (Diluted) | $0.08 | +14.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $19K | -91.7% |
| Current Assets | $25K | -92.6% |
| Total Assets | $27K | -92.0% |
| Current Liabilities | $769K | +968.1% |
| Stockholders' Equity | -$742K | -177.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$532K | +55.8% |
| Financing Cash Flow | $321K | -72.0% |